Sheel Biotech Limited (NSE:SHEEL)
India
· Delayed Price · Currency is INR 46.90
+1.90 (4.22%)
At close: Apr 28, 2026
Sheel Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Net Income | 146.09 | 106.36 | 104.75 | 50.77 | 45.1 | - |
| Depreciation & Amortization | 9.78 | 9 | 9.87 | 10.17 | 9.4 | - |
| Loss (Gain) From Sale of Assets | -1.13 | -1.13 | - | - | -0.29 | - |
| Loss (Gain) From Sale of Investments | -1.88 | -1.88 | - | - | - | - |
| Other Operating Activities | 20.13 | 17.75 | 19.47 | 28.02 | 10.41 | - |
| Change in Accounts Receivable | -47.79 | 26.22 | -16.55 | 86.61 | -40.22 | - |
| Change in Inventory | -6.46 | -66.11 | -134.74 | -74.72 | -55.53 | - |
| Change in Accounts Payable | -1.38 | -4.46 | -36.17 | -1.37 | 49.35 | - |
| Change in Other Net Operating Assets | -89.69 | 6.33 | 44.19 | -6.55 | 3.68 | - |
| Operating Cash Flow | 27.68 | 92.08 | -9.2 | 92.92 | 21.91 | - |
| Operating Cash Flow Growth | - | - | - | 324.19% | - | - |
| Capital Expenditures | -10.27 | -12.38 | -2.94 | -11.55 | -12.09 | - |
| Sale of Property, Plant & Equipment | 2 | 2 | - | - | 0.52 | - |
| Investment in Securities | 1.98 | 1.98 | - | - | -7.92 | - |
| Other Investing Activities | -13.68 | -14.1 | 0.42 | -10.21 | -1.67 | - |
| Investing Cash Flow | -4.95 | -22.51 | -2.52 | -21.75 | -21.16 | - |
| Short-Term Debt Issued | - | 1,095 | 1,161 | 979.32 | 3.98 | - |
| Long-Term Debt Issued | - | 48.45 | 20.89 | 32.91 | 18.39 | - |
| Total Debt Issued | 1,201 | 1,143 | 1,182 | 1,012 | 22.37 | - |
| Short-Term Debt Repaid | - | -1,102 | -1,126 | -984.01 | - | - |
| Long-Term Debt Repaid | - | -102.9 | -12.62 | -72.34 | - | - |
| Total Debt Repaid | -1,200 | -1,205 | -1,138 | -1,056 | - | - |
| Net Debt Issued (Repaid) | 0.49 | -61.78 | 43.69 | -44.12 | 22.37 | - |
| Issuance of Common Stock | - | 20.23 | - | - | - | - |
| Common Dividends Paid | -14.95 | -14.95 | -13.26 | -12.84 | -12.85 | - |
| Other Financing Activities | -17.97 | -14.46 | -14.79 | -15.21 | -11.78 | - |
| Financing Cash Flow | -32.43 | -70.96 | 15.64 | -72.17 | -2.26 | - |
| Net Cash Flow | -9.7 | -1.39 | 3.93 | -1 | -1.51 | - |
| Free Cash Flow | 17.42 | 79.7 | -12.14 | 81.38 | 9.81 | - |
| Free Cash Flow Growth | - | - | - | 729.34% | - | - |
| Free Cash Flow Margin | 1.55% | 7.83% | -1.31% | 10.16% | 1.39% | - |
| Free Cash Flow Per Share | 1.19 | 5.40 | -0.84 | 5.61 | 0.68 | - |
| Cash Interest Paid | 17.97 | 14.46 | 11.5 | 11.17 | 9 | - |
| Cash Income Tax Paid | 19.99 | 19.9 | 13.24 | 0.02 | 1.78 | - |
| Levered Free Cash Flow | - | 42.92 | -52.53 | 38.35 | -26.53 | - |
| Unlevered Free Cash Flow | - | 51.95 | -45.34 | 45.34 | -20.91 | - |
| Change in Working Capital | -145.31 | -38.02 | -143.28 | 3.97 | -42.72 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.